Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Oncosec Medical (ONCS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
OncoSec to Present at the 31st Annual ROTH Conference

OncoSec Medical Incorporated (OncoSec) (NASDAQ:ONCS), a company developing intratumoral cancer immunotherapies, today announced that management will present in the 31st Annual ROTH Conference taking place...

ONCS : 0.50 (unch)
Biotech Companies Turn Their Attention to Cancer as Global Incidences Grow

In 2018, cancer was the second leading cause of death around the globe. Cancer was responsible for an estimated 9.6 million deaths in that year, or approximately one in six deaths, according to the World...

CANF : 1.29 (+4.03%)
CYCC : 0.95 (unch)
ONCS : 0.50 (unch)
SNETD : 0.3900 (+14.71%)
SNET : 0.0224 (+111.32%)
BLRX : 0.44 (-1.74%)
OncoSec Announces Poster Presentation at 2019 American Association for Cancer Research Annual Meeting

OncoSec Medical Incorporated (OncoSec) (NASDAQ:ONCS), a company developing novel cancer immunotherapies, today announced it will present pre-clinical data regarding its new anti-tumor product candidate...

ONCS : 0.50 (unch)
OncoSec To Present At BIO CEO & Investor Conference

OncoSec Medical Incorporated (OncoSec) (NASDAQ:ONCS), a company developing intratumoral cancer immunotherapies, today announced that Dan O'Connor, President, Director & Chief Executive Officer, will present...

ONCS : 0.50 (unch)
OncoSec Provides KEYNOTE-695 Clinical Update And Outlines 2019 Milestones

OncoSec Medical Incorporated (OncoSec) (NASDAQ:ONCS), a company developing intratumoral cancer immunotherapies, provided a clinical data update today regarding KEYNOTE-695, as well as progress of its ongoing...

ONCS : 0.50 (unch)
Safer Treatments Gain Market Traction as Cancer Occurence Continues to Grow

FinancialBuzz.com News Commentary

RNN : 0.54 (+1.89%)
OGEN : 0.60 (-3.23%)
ONCS : 0.50 (unch)
SNETD : 0.3900 (+14.71%)
SNET : 0.0224 (+111.32%)
SNSS : 1.28 (+2.40%)
OncoSec and Gynecologic Oncology Group (GOG) Foundation, Inc. to Conduct a Pivotal Study of TAVO(TM) with Standard of Care KEYTRUDA® for Treatment of Late Stage Cervical Cancer

OncoSec Medical Incorporated (OncoSec) (NASDAQ:ONCS), a company developing novel cancer immunotherapies, today announced it has established a collaboration with the GOG Foundation, Inc., (GOG Foundation),...

ONCS : 0.50 (unch)
OncoSec Announces Appointment Of Joon Kim, J.D., To Board Of Directors

OncoSec Medical Incorporated (OncoSec) (NASDAQ:ONCS), a company developing intratumoral cancer immunotherapies, announced today that Joon Kim, J.D., a partner at Lee & Ko, has been appointed to OncoSec's...

ONCS : 0.50 (unch)
OncoSec Announces Publication of New Research in the Journal Immunity Highlighting the Role of IL-12 in Anti-PD-1 Therapies with TAVO(TM) Directly Activating TILs in Patients

OncoSec Medical Incorporated (OncoSec) (NASDAQ:ONCS), a company developing novel cancer immunotherapies, today announced the publication of new research in the journal Immunity that finds that IL-12 producing...

ONCS : 0.50 (unch)
OncoSec Reports Updated Tumor Responses in KEYNOTE-695 Study of TAVO(TM) + KEYTRUDA® in Refractory Metastatic Melanoma

OncoSec Medical Incorporated (OncoSec) (NASDAQ:ONCS), a company developing novel cancer immunotherapies, today announced an update regarding tumor responses in its KEYNOTE-695 global, multicenter Phase...

ONCS : 0.50 (unch)
OncoSec Presents New Data Showing A Single Cycle Of Monotherapy TAVO(TM) Can Generate Productive Immune Responses In Triple Negative Breast Cancers (TNBC)

OncoSec Medical Incorporated (OncoSec) (NASDAQ:ONCS), a company developing intratumoral cancer immunotherapies, announced today the presentation of new data that suggests treatment with TAVO(TM) (tavokinogene...

ONCS : 0.50 (unch)
OncoSec Receives $7 Million Investment From Alpha Holdings At $1.50 Per Share

OncoSec Medical Incorporated (OncoSec) (NASDAQ: ONCS), a company developing intratumoral cancer immunotherapies, announced today that the Company has received a $7.0 million investment at $1.50 per share...

ONCS : 0.50 (unch)
OncoSec Presents New Data During Oral Presentation At Melanoma Bridge Demonstrating Intratumoral Monotherapy TAVO(TM) Induces Abscopal Responses In Metastatic Melanoma Patients

OncoSec Medical Incorporated (OncoSec) (NASDAQ: ONCS), a company developing intratumoral cancer immunotherapies, announced today the presentation of new data from the company's Phase 2 study of TAVO(TM)...

ONCS : 0.50 (unch)
OncoSec Expands Relationship with Merck, Announces Clinical Collaboration to Evaluate Combination of ImmunoPulse® IL-12 and KEYTRUDA® (pembrolizumab) for Triple Negative Breast Cancer

OncoSec Medical Incorporated (OncoSec) (NASDAQ:ONCS), a company developing intratumoral cancer immunotherapies, has entered a clinical trial collaboration and supply agreement with Merck (known as MSD...

ONCS : 0.50 (unch)
Free Research Reports on These Biotech Stocks -- MannKind, Marinus Pharma, Mirati Therapeutics, and OncoSec Medical

If you want a free Stock Review on MNKD, MRNS, MRTX, and ONCS sign up now at www.wallstequities.com/registration. WallStEquities.com has initiated research coverage on MannKind Corp. (NASDAQ: MNKD), Marinus...

ONCS : 0.50 (unch)
MRTX : 75.43 (+3.00%)
MNKD : 1.98 (-7.04%)
MRNS : 3.82 (-0.52%)
OncoSec to Present at Eighth Annual BioNJ BioPartnering Conference

OncoSec Medical Incorporated (OncoSec) (NASDAQ:ONCS), a company developing intratumoral cancer immunotherapies, today announced that Daniel J. O'Connor, Chief Executive Officer of OncoSec, will present...

ONCS : 0.50 (unch)
OncoSec Announces PISCES/KEYNOTE-695 Trial-in-Progress Poster Presentation at Upcoming ASCO 2018 Annual Meeting

OncoSec Medical Incorporated (OncoSec) (NASDAQ: ONCS), a company developing intratumoral cancer immunotherapies, will present a trial-in-progress poster presentation from its global, multi-center, registration-directed...

ONCS : 0.50 (unch)
OncoSec Provides Highlights from Research Reception at AACR Annual Meeting 2018

OncoSec Medical Incorporated (OncoSec) (NASDAQ: ONCS), a company developing intratumoral cancer immunotherapies, today provided highlights from its Research Reception held on Sunday, April 15, 2018, during...

ONCS : 0.50 (unch)
OncoSec to Host Research Reception During the 2018 American Association of Cancer Research Annual Meeting

OncoSec Medical Incorporated (OncoSec) (NASDAQ:ONCS), a company developing intratumoral cancer immunotherapies, today announced it will host a Research Reception at the 2018 American Association of Cancer...

ONCS : 0.50 (unch)
Biotech Market Poised to Reach 2015 Highs

FN Media Group Presents Microcapspeculators.com News Commentary

PPCHD : 1.2000 (+20.00%)
INNT : 1.92 (-2.54%)
PPCB : 0.0135 (+16.38%)
ONCS : 0.50 (unch)
GERN : 1.64 (-2.96%)
LPTX : 1.97 (unch)

Van Meerten Stock Picks

Trilogy Metals - Pick of the Day
My Stock Pick of the Day belongs metal mining company Trilogy Metals(TMQ).
TMQ +0.11
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar